 |
Video: What is a Stock Split?
|
 |
Lineage Cell Therapeutics is a clinical-stage biotechnology company targeting degenerative diseases. Co.'s programs based on two main proprietary technology platforms: cell replacement and cell/drug delivery. With its cell replacement platform, Co. is creating new cells and tissues with its pluripotent and progenitor cell technologies. These cells and tissues are developed to replace those that are either rendered dysfunctional due to degenerative diseases. Co.'s cell/drug delivery programs are based upon its proprietary HyStem® cell and drug delivery matrix technology. HyStem® is designed to provide for the transfer, retention, engraftment and metabolic support. According to our BTX split history records, BTX has had 1 split. | |
 |

BTX (BTX) has 1 split in our BTX split history database. The split for BTX took place on October 31, 1997. This was a 3 for 1
split, meaning for each share of BTX owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split.
When a company such as BTX splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the BTX split history from start to finish, an original position size of 1000 shares would have turned into 3000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into BTX shares, starting with a $10,000 purchase of BTX, presented on a split-history-adjusted basis factoring in the complete BTX split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/03/2011 |
|
End date: |
08/09/2019 |
|
Start price/share: |
$8.06 |
|
End price/share: |
$0.92 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-88.59% |
|
Average Annual Total Return: |
-22.68% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,141.21 |
|
Years: |
8.44 |
|
|
 |
Date |
Ratio |
10/31/1997 | 3 for 1
|
|
 |